Hemovent GmbH was founded by successful entrepreneurs and medical device experts Christof Lenz and Dr. Oliver Marseille.
Hemovent GmbH is a privately held company whose first-of-its-kind portable ECMO system is designed to disrupt the market for supporting or replacing heart and lung functions.
The innovative Hemovent portable ECMO system is a disruptive technology offering unrivaled mobility, versatility, and simplicity in a billion-dollar market.
Hemovent is developing the world’s first self-contained and fully portable ECMO system, designed to reduce standard size and complexity by 90% and cost by 50%.
Hemovent GmbH is an emerging medical device company that has developed disruptive technology: the world’s smallest and first self-contained fully portable Extra Corporeal Membrane Oxygenation (ECMO) system that supports or replaces heart and lung function in the event of cardiac and respiratory failure.